GI
BBNX

GAMMA Investing’s Beta Bionics BBNX Stock Holding History

GAMMA Investing’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.62K Sell
486
-108
-18% -$1.28K ﹤0.01% 3317
2026
Q1 		$5.95K Sell
594
-185
-24% -$2.74K ﹤0.01% 3301
2025
Q4 		$23.7K Buy
779
+155
+25% +$4.14K ﹤0.01% 2521
2025
Q3 		$12.4K Buy
624
+87
+16% +$1.53K ﹤0.01% 2776
2025
Q2 		$7.82K Buy
537
+524
+4,031% +$7.42K ﹤0.01% 2930
2025
Q1 		$159 Buy
+13
New +$242 ﹤0.01% 3766

Other funds holding BBNX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IWM
Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing's BBNX Position: Q2 2026 in Review

GAMMA Investing reduced its Beta Bionics (BBNX) stake by 18% in Q2 2026, selling an estimated $1.28K and leaving 486 shares worth $7.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3317.

GAMMA Investing first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $23.7K in Q4 2025. 19 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • GAMMA Investing held 486 shares of Beta Bionics worth $7.62K as of Q2 2026.
  • GAMMA Investing sold 108 Beta Bionics shares in Q2 2026, an estimated $1.28K.
  • Beta Bionics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3317 holding.
  • GAMMA Investing first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • GAMMA Investing's Beta Bionics position peaked at $23.7K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.